Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. currently has 1 pending office action within the Chemistry & Materials technology area. This action is being handled by 1 distinct examiner, YOH, JULIUS FRANCIS, who is the busiest examiner for the company. The involvement of 1 distinct art unit indicates that the company's current prosecution is concentrated within a specific technical niche of Chemistry & Materials.
The 1 busiest examiner pending action assigned to YOH, JULIUS FRANCIS represents the total of 1 pending office action for the portfolio. This indicates a highly centralized prosecution environment where a single examiner oversees all active matters. The 1 distinct art unit involved further suggests that the technical subject matter is not distributed across different examination groups.
Practitioners should focus on the specific requirements and examination style of YOH, JULIUS FRANCIS. Since there is only 1 pending office action and 1 distinct examiner, the strategy is currently very focused. The resolution of the 1 busiest examiner pending action in the 1 distinct art unit will be the primary driver of the portfolio's progress in the near future.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOH, JULIUS FRANCIS | 1 | 75.0% | +33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697740 | MICROFLUIDIC CHIP AND MICROFLUIDIC CHIP DETECTION SYSTEM | YOH, JULIUS FRANCIS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18697740 | MICROFLUIDIC CHIP AND MICROFLUIDIC CHIP DETECTION SYSTEM | YOH, JULIUS FRANCIS | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18697740 | MICROFLUIDIC CHIP AND MICROFLUIDIC CHIP DETECTION SYSTEM | YOH, JULIUS FRANCIS | 1799 | §102§103§112 | Non-Final OA | — | Pending | Apr 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Julius Francis Yoh has the most, with 1 of BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
